Could imatinib replace surgery in esophageal gastrointestinal stromal tumor

Suhail N. Al-Salam, Hassan A. El-Teraifi, Mazen S. Taha

Research output: Contribution to journalArticlepeer-review

4 Citations (Scopus)

Abstract

Gastrointestinal stromal tumors (GISTs) are cellular spindle, or epithelioid tumors that occur in the stomach, intestine, and rarely in the esophagus. A 61-year-old man was complaining of resistant dry cough with dysphagia for one month duration. Upper gastrointestinal tract endoscopic examination showed a polypoid mass 30 cm from the incisors obstructing 50% of the lumen, where multiple biopsies were taken. Magnetic resonance imaging (MRI) showed a mass in the wall of the esophagus extending into the thoracic cavity. Histologically, the stained sections with the routine hematoxylin and eosin as well as the immunohistochemical stains for CD117, CD34, S100, vimentin, and smooth muscle actin confirmed the diagnosis of esophageal GIST. The patient was treated with imatinib, 400 mg/day. There was a dramatic reduction in the size of the tumor with successful improvement of his symptoms after 2 months of treatment, which was confirmed by repeated upper GIT endoscopy, and MRI.

Original languageEnglish
Pages (from-to)1236-1239
Number of pages4
JournalSaudi Medical Journal
Volume27
Issue number8
Publication statusPublished - Aug 2006

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Could imatinib replace surgery in esophageal gastrointestinal stromal tumor'. Together they form a unique fingerprint.

Cite this